Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
Strut Health at a Glance
- What it is
- Oral GLP-1 lozenges for the needle-averse — from a company the FDA found was labelling products as its own when it was not the compounder
- Medication type
- Compounded only
- Medications offered
- Compounded semaglutide — oral lozenge
- Compounded semaglutide — injection
- Compounded tirzepatide
- Pricing
- Oral semaglutide lozenges reported at $99–$149/mo; injectable $149–$289/mo — figures vary widely by source
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is Strut Health?
Strut Health is a telehealth company offering compounded GLP-1s in an unusual format: an oral lozenge alongside the standard injection. For the substantial number of people whose real barrier to treatment is the needle rather than the cost, that is a genuine differentiator, and reviewers report responsive physicians and shipping arriving within five to seven business days.
On 20 February 2026 the FDA issued Strut Health, LLC a warning letter (reference 721448) through its Office of Compounding Quality and Compliance. Having reviewed struthealth.com in December 2025, the FDA made two findings. First, that claims on the site implied the compounded semaglutide and tirzepatide products had been FDA-approved or evaluated for safety and effectiveness when they had not. Second — and more specifically — that the products pictured on the website carried labels identifying "Strut", suggesting Strut was the compounder of those drugs "when in fact it is not". The FDA concluded the products were misbranded under sections 502(a) and 502(bb) of the Federal Food, Drug and Cosmetic Act and introduced into interstate commerce in violation of section 301(a).
That second finding is worth dwelling on, because it sits directly against how the company has been described elsewhere. Some third-party coverage states that Strut operates its own licensed compounding pharmacy. The FDA, having examined the matter, determined that Strut was not the compounder of the products bearing its name. Where a regulator's finding and a marketing claim conflict, we go with the regulator.
The service record adds to the picture. Strut carries a D+ rating from the BBB. Negative reviews concentrate on subscription friction rather than the medication: login and password loops that prevent customers cancelling online, unexpected auto-refill charges, and shipping delays.
How the Program Works
- Consultation process
- Online intake with physician review. Reviewers describe the physicians as responsive, which is a genuine positive in a category where support complaints are endemic.
- Eligibility
- Clinician-assessed at intake. Strut does not publish a BMI threshold or a list of states it serves.
- Provider involvement
- Licensed physicians prescribe and review. Note the FDA's finding that Strut is not the compounder of the medication sold under its name — the dispensing arrangement is not what the labelling suggested.
- Lab requirements
- Not published as a universal requirement.
- Pharmacy fulfillment
- This is the crux of the FDA letter. Products pictured on the site bore labels identifying "Strut", which the FDA found suggested Strut compounded them when it did not. Treat any claim that Strut operates its own compounding pharmacy with caution, and ask directly which pharmacy fills your prescription.
- Shipping frequency
- Typically five to seven business days from order, on a subscription with auto-refill. Unexpected auto-refill charges appear in customer complaints.
- Support services
- Physician access and messaging. The recurring complaint is not responsiveness but cancellation: customers describe login and password loops that prevent them cancelling online.
Strut Health Pricing
- Membership fee
- None published separately.
- Medication fee
- Reported at $99 to $149/month for the oral semaglutide lozenge and $149 to $289/month for the injectable. Other sources report $249/month for the oral lozenge at standard doses rising to $349/month at higher doses. That is a wide spread for the same product.
- Cancellation policy
- The dominant complaint against this company. Customers describe login and password loops that prevent cancellation through the website, alongside unexpected auto-refill charges. If you subscribe, establish a working cancellation route — ideally by email, with confirmation — before you need it.
- Refund policy
- Not published. Compounded medication is not returnable once dispensed.
- Insurance
- Cash-pay. Compounded medication is never covered by insurance.
- HSA / FSA
- Not published. Confirm with your plan administrator.
Pricing details worth knowing
- Published pricing varies substantially between sources — from $99 to $349 a month for the oral lozenge depending on who is reporting. Confirm your own rate at checkout.
- Pricing appears to rise with dose on the oral lozenge, so budget for a maintenance dose rather than a starting one.
- The oral lozenge is a compounded formulation. There is no clinical trial evidence for compounded sublingual or lozenge semaglutide — the FDA-approved oral options are the Wegovy tablet and Foundayo.
- Auto-refill is the default. Customers report unexpected refill charges, so note your billing date.
Prices change. Every figure above was taken from Strut Health's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- An oral lozenge format, which genuinely helps people whose barrier is the needle
- Reviewers consistently describe the physicians as responsive
- Shipping typically arrives within five to seven business days
- Entry pricing for the oral format is competitive at the low end of the reported range
- Offers both semaglutide and tirzepatide
Cons
- FDA warning letter of 20 February 2026 finding the products misbranded
- The FDA specifically found labels bearing the Strut name suggested it was the compounder when it was not
- D+ rating from the BBB
- Customers report login and password loops preventing online cancellation
- Unexpected auto-refill charges recur in complaints
- Reported pricing ranges from $99 to $349 a month for the same oral product
Who Strut Health May Be Best For
Very few readers while the regulatory finding stands. If a non-injection route is what you need, there are alternatives without a misbranding letter.
Anyone who has read the FDA letter, wants a lozenge specifically, and will set up a cancellation route before subscribing
Limitations
Read the FDA warning letter first — search the FDA warning letter database for "Strut Health" or reference 721448. It is short and specific.
Ask which pharmacy actually compounds your medication, and do not rely on the label to tell you. That is precisely what the FDA objected to.
Establish a cancellation route that does not depend on logging in, before you subscribe. Cancellation friction is the single most common complaint here.
The oral lozenge has no clinical trial evidence behind that formulation. Convenience is real; equivalence to the injection is not established.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to Strut Health — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to Strut Health
Willow
Also offers an oral semaglutide tablet, at a flat $299/mo, without a misbranding letter
Read review →NovoCare Pharmacy
The FDA-approved Wegovy pill at $149/mo, with real trial evidence behind the oral formulation
Read review →Sunlight
Names six compounding pharmacies outright, so the question the FDA raised about Strut does not arise
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats Strut Health for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
Did Strut Health receive an FDA warning letter?
Yes. The FDA issued Strut Health, LLC dba Strut a warning letter dated 20 February 2026, reference 721448, through its Office of Compounding Quality and Compliance. Following a December 2025 review of struthealth.com, the FDA found that claims on the site implied its compounded semaglutide and tirzepatide had been FDA-approved or evaluated for safety and effectiveness when they had not, and that products pictured carried labels identifying "Strut" — suggesting Strut was the compounder "when in fact it is not". The FDA concluded the products were misbranded under sections 502(a) and 502(bb) of the FD&C Act.
Does Strut Health run its own compounding pharmacy?
Some third-party coverage says it does. The FDA, having reviewed the matter directly, found that Strut was not the compounder of the products bearing its name — that was the substance of one of its two findings in the February 2026 warning letter. When a regulator's determination and a marketing description conflict, we report the regulator's. If this matters to you, ask Strut in writing which pharmacy compounds your medication.
How much does Strut Health cost?
Reported figures vary more than at almost any provider we have reviewed. Sources put the oral semaglutide lozenge anywhere from $99 to $149/month, and other reporting puts it at $249/month at standard doses rising to $349/month at higher doses. Injectable semaglutide is reported at $149 to $289/month. Pricing appears to scale with dose on the oral format. Confirm your own maintenance-dose price at checkout rather than relying on any published figure.
Is the oral GLP-1 lozenge as good as the injection?
There is no evidence establishing that, and you should not assume it. Strut's lozenge is a compounded formulation, and no clinical trial has evaluated compounded sublingual or lozenge semaglutide for weight loss. The FDA-approved oral GLP-1s are the Wegovy tablet and Foundayo, both of which have trial evidence behind them; NovoCare publishes the Wegovy pill at $149/month. The lozenge may well suit someone who cannot face injections — but convenience and demonstrated equivalence are different claims.
Can I cancel Strut Health easily?
Customers report otherwise, and it is the most consistent complaint against the company: login and password loops that prevent cancellation through the website, together with unexpected auto-refill charges. If you subscribe, establish a cancellation route that does not depend on the portal — email is best — and keep written confirmation of any cancellation request.
Who should not use Strut Health?
Anyone uncomfortable with the February 2026 misbranding finding, which we would suggest is most readers given that alternatives exist. Anyone who wants certainty about who makes their medication. Anyone likely to need a clean cancellation. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis. Common side effects include nausea, vomiting, diarrhoea and constipation during titration. A licensed clinician who knows your history should decide.
The Verdict
Strut Health sells compounded semaglutide as an oral lozenge as well as by injection, which is a genuine option for people blocked by needles. It received an FDA warning letter on 20 February 2026 finding its products misbranded, specifically because labels bearing the Strut name suggested it was the compounder when the FDA determined it was not. Its BBB rating is D+, and customers report being unable to cancel online.
Opens Strut Health's official site · Verify current pricing there
Compare Every Provider Side by Side
See how Strut Health stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from Strut Health's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where Strut Health does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- US Food and Drug Administration warning letter to Strut Health, LLC dba Strut, reference 721448, dated 20 February 2026, issued by the Office of Compounding Quality and Compliance, CDER — struthealth.com reviewed December 2025; findings that site claims implied FDA approval or evaluation when none existed, and that pictured product labels identifying "Strut" suggested Strut was the compounder "when in fact it is not"; products found misbranded under sections 502(a) and 502(bb) of the FD&C Act and introduced into interstate commerce in violation of section 301(a)
- FDA press announcement on warning letters issued to 30 telehealth companies over illegal marketing of compounded GLP-1s
- Third-party reporting: oral semaglutide lozenges at $99–$149/month and injectable at $149–$289/month, with other sources reporting $249/month standard and $349/month at higher doses; BBB rating of D+; shipping typically 5–7 business days
- Customer feedback describing responsive physicians and the convenience of the lozenge format, alongside login and password loops preventing online cancellation, unexpected auto-refill charges and shipping delays
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.